JS-K, a nitric oxide-releasing prodrug, induces breast cancer cell death while sparing normal mammary epithelial cells.

JS-K, a nitric oxide-releasing prodrug, induces breast cancer cell death while sparing normal mammary epithelial cells.
复制标题

DOI:
10.3892/ijo.2011.925
复制
发表时间:
2011-04
影响因子:
5.2
通讯作者:
Tari AM
Tari AM
中科院分区:
医学2区
文献类型:
--
作者:
McMurtry V;Saavedra JE;Nieves-Alicea R;Simeone AM;Keefer LK;Tari AM

文献摘要

参考文献

被引文献

相似文献

减少副作用的靶向治疗是癌症研究的主要目标。我们研究了JS-K(一种一氧化氮(NO)前药,设计用于在适当激活时释放高水平NO)对人乳腺癌细胞系、非转化人MCF-10A乳腺细胞和正常人乳腺上皮细胞(HMEC)的影响。采用细胞活力测定、流式细胞术、电镜和Western blot分析等方法研究JS-K对乳腺癌细胞和乳腺上皮细胞的作用。孵育3天后,JS-K对乳腺癌细胞的IC 50范围为0.8至3 μ M。然而,在10 μ M浓度下,JS-K仅使MCF-10A细胞的活力降低20%,并且HMEC不受10 μ M JS-K的影响。流式细胞仪检测结果显示,JS-K可增加乳腺癌细胞凋亡率。有趣的是,流式细胞术表明JS-K增加了乳腺癌细胞中酸性囊泡细胞器的形成,表明JS-K诱导了乳腺癌细胞中的自噬。电子显微镜证实,JS-K处理的乳腺癌细胞发生自噬细胞死亡。Western blot分析显示,JS-K诱导乳腺癌细胞中另一种自噬标志物微管轻链3-II的表达。然而,JS-K在正常人乳腺上皮细胞中不诱导凋亡或自噬。这些数据表明,JS-K选择性地诱导乳腺癌细胞中的程序性细胞死亡,而在相同条件下保留正常乳腺上皮细胞。JS-K的选择性抗肿瘤活性保证了其在乳腺肿瘤中的进一步研究。
Targeted therapy with reduced side effects is a major goal in cancer research. We investigated the effects of JS-K, a nitric oxide (NO) prodrug designed to release high levels of NO when suitably activated, on human breast cancer cell lines, on non-transformed human MCF-10A mammary cells, and on normal human mammary epithelial cells (HMECs). Cell viability assay, flow cytometry, electron microscopy, and Western blot analysis were used to study the effects of JS-K on breast cancer and on mammary epithelial cells. After a 3-day incubation, the IC50s of JS-K against the breast cancer cells ranged from 0.8 to 3 μM. However, JS-K decreased the viability of the MCF-10A cells by only 20% at 10-μM concentration, and HMECs were unaffected by 10 μM JS-K. Flow cytometry indicated that JS-K increased the percentages of breast cancer cells under-going apoptosis. Interestingly, flow cytometry indicated that JS-K increased acidic vesicle organelle formation in breast cancer cells, suggesting that JS-K induced autophagy in breast cancer cells. Electron microscopy confirmed that JS-K-treated breast cancer cells underwent autophagic cell death. Western blot analysis showed that JS-K induced the expression of microtubule light chain 3-II, another autophagy marker, in breast cancer cells. However, JS-K did not induce apoptosis or autophagy in normal human mammary epithelial cells. These data indicate that JS-K selectively induces programmed cell death in breast cancer cells while sparing normal mammary epithelial cells under the same conditions. The selective anti-tumor activity of JS-K warrants its further investigation in breast tumors.
DOI: 10.1093/carcin/23.6.929
发表时间: 2002-06-01
期刊: CARCINOGENESIS
影响因子: 4.7
作者:
Heigold, S;Sers, C;Bauer, G
通讯作者: Bauer, G
DOI: 10.1083/jcb.152.4.657
发表时间: 2001-02-19
期刊: The Journal of cell biology
影响因子: --
作者:
Mizushima N;Yamamoto A;Hatano M;Kobayashi Y;Kabeya Y;Suzuki K;Tokuhisa T;Ohsumi Y;Yoshimori T
通讯作者: Yoshimori T
DOI: 10.1038/bjc.1989.375
发表时间: 1989-12
影响因子: 8.8
作者:
Howie, A F;Miller, W R;Hawkins, R A;Hutchinson, A R;Beckett, G J
通讯作者: Beckett, G J
DOI: 10.1074/jbc.275.2.992
发表时间: 2000-01-14
影响因子: 4.8
作者:
Petiot, A;Ogier-Denis, E;Codogno, P
通讯作者: Codogno, P
DOI: 10.1016/j.bbrc.2004.10.010
发表时间: 2004-12-03
影响因子: 3.1
作者:
Bishop, A;Yet, SF;Demple, B
通讯作者: Demple, B